Selected research
Industry Research
Bispecific and Multispecific Antibody Service Industry Research Report 2026
Market perspective
The global Bispecific and Multispecific Antibody Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bispecific and Multispecific Antibody Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bispecific and Multispecific Antibody Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bispecific and Multispecific Antibody Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bispecific and Multispecific Antibody Service include evitria, WuXi Biologics, Sino Biological, Alloy Therapeutics, Biointron, Akeso, Inc, Absolute Antibody, Zymeworks and Genedata Biologics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bispecific and Multispecific Antibody Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bispecific and Multispecific Antibody Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bispecific and Multispecific Antibody Service Market by Company
evitria
WuXi Biologics
Sino Biological
Alloy Therapeutics
Biointron
Akeso, Inc
Absolute Antibody
Zymeworks
Genedata Biologics
Creative Biolabs
ACROBiosystems
Invenra
ProteoGenix
Bispecific and Multispecific Antibody Service Segment by Type
Biochemical Characterization Service
Structural Characterization Service
Functional Characterization Service
Others
Bispecific and Multispecific Antibody Service Segment by Application
Cancer Treatment
Autoimmune Diseases
Infectious Diseases
Others
Bispecific and Multispecific Antibody Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bispecific and Multispecific Antibody Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bispecific and Multispecific Antibody Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bispecific and Multispecific Antibody Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bispecific and Multispecific Antibody Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biochemical Characterization Service
- Structural Characterization Service
- Functional Characterization Service
- Others
Applications
- Cancer Treatment
- Autoimmune Diseases
- Infectious Diseases
- Others
Companies covered
- evitria
- WuXi Biologics
- Sino Biological
- Alloy Therapeutics
- Biointron
- Akeso, Inc
- Absolute Antibody
- Zymeworks
- Genedata Biologics
- Creative Biolabs
- ACROBiosystems
- Invenra
- ProteoGenix
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bispecific and Multispecific Antibody Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Biochemical Characterization Service
- 2.2.3 Structural Characterization Service
- 2.2.4 Functional Characterization Service
- 2.2.5 Others
- 2.3 Bispecific and Multispecific Antibody Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancer Treatment
- 2.3.3 Autoimmune Diseases
- 2.3.4 Infectious Diseases
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Bispecific and Multispecific Antibody Service Breakdown Data by Type
- 3.1 Global Bispecific and Multispecific Antibody Service Historic Market Size by Type (2021-2026)
- 3.2 Global Bispecific and Multispecific Antibody Service Forecasted Market Size by Type (2027-2032)
4 Bispecific and Multispecific Antibody Service Breakdown Data by Application
- 4.1 Global Bispecific and Multispecific Antibody Service Historic Market Size by Application (2021-2026)
- 4.2 Global Bispecific and Multispecific Antibody Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bispecific and Multispecific Antibody Service Market Perspective (2021-2032)
- 5.2 Global Bispecific and Multispecific Antibody Service Growth Trends by Region
- 5.2.1 Global Bispecific and Multispecific Antibody Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bispecific and Multispecific Antibody Service Historic Market Size by Region (2021-2026)
- 5.2.3 Bispecific and Multispecific Antibody Service Forecasted Market Size by Region (2027-2032)
- 5.3 Bispecific and Multispecific Antibody Service Market Dynamics
- 5.3.1 Bispecific and Multispecific Antibody Service Industry Trends
- 5.3.2 Bispecific and Multispecific Antibody Service Market Drivers
- 5.3.3 Bispecific and Multispecific Antibody Service Market Challenges
- 5.3.4 Bispecific and Multispecific Antibody Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bispecific and Multispecific Antibody Service Players by Revenue
- 6.1.1 Global Top Bispecific and Multispecific Antibody Service Players by Revenue (2021-2026)
- 6.1.2 Global Bispecific and Multispecific Antibody Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Bispecific and Multispecific Antibody Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bispecific and Multispecific Antibody Service Head Office and Area Served
- 6.4 Global Bispecific and Multispecific Antibody Service Players, Product Type & Application
- 6.5 Global Bispecific and Multispecific Antibody Service Manufacturers Established Date
- 6.6 Global Bispecific and Multispecific Antibody Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bispecific and Multispecific Antibody Service Market Size (2021-2032)
- 7.2 North America Bispecific and Multispecific Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
- 7.4 North America Bispecific and Multispecific Antibody Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bispecific and Multispecific Antibody Service Market Size (2021-2032)
- 8.2 Europe Bispecific and Multispecific Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
- 8.4 Europe Bispecific and Multispecific Antibody Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size (2021-2032)
- 9.2 Asia-Pacific Bispecific and Multispecific Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bispecific and Multispecific Antibody Service Market Size (2021-2032)
- 10.2 South America Bispecific and Multispecific Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
- 10.4 South America Bispecific and Multispecific Antibody Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bispecific and Multispecific Antibody Service Market Size (2021-2032)
- 11.2 Middle East & Africa Bispecific and Multispecific Antibody Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bispecific and Multispecific Antibody Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 evitria
- 12.1.1 evitria Company Information
- 12.1.2 evitria Business Overview
- 12.1.3 evitria Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.1.4 evitria Bispecific and Multispecific Antibody Service Product Portfolio
- 12.1.5 evitria Recent Developments
- 12.2 WuXi Biologics
- 12.2.1 WuXi Biologics Company Information
- 12.2.2 WuXi Biologics Business Overview
- 12.2.3 WuXi Biologics Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.2.4 WuXi Biologics Bispecific and Multispecific Antibody Service Product Portfolio
- 12.2.5 WuXi Biologics Recent Developments
- 12.3 Sino Biological
- 12.3.1 Sino Biological Company Information
- 12.3.2 Sino Biological Business Overview
- 12.3.3 Sino Biological Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.3.4 Sino Biological Bispecific and Multispecific Antibody Service Product Portfolio
- 12.3.5 Sino Biological Recent Developments
- 12.4 Alloy Therapeutics
- 12.4.1 Alloy Therapeutics Company Information
- 12.4.2 Alloy Therapeutics Business Overview
- 12.4.3 Alloy Therapeutics Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.4.4 Alloy Therapeutics Bispecific and Multispecific Antibody Service Product Portfolio
- 12.4.5 Alloy Therapeutics Recent Developments
- 12.5 Biointron
- 12.5.1 Biointron Company Information
- 12.5.2 Biointron Business Overview
- 12.5.3 Biointron Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.5.4 Biointron Bispecific and Multispecific Antibody Service Product Portfolio
- 12.5.5 Biointron Recent Developments
- 12.6 Akeso, Inc
- 12.6.1 Akeso, Inc Company Information
- 12.6.2 Akeso, Inc Business Overview
- 12.6.3 Akeso, Inc Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.6.4 Akeso, Inc Bispecific and Multispecific Antibody Service Product Portfolio
- 12.6.5 Akeso, Inc Recent Developments
- 12.7 Absolute Antibody
- 12.7.1 Absolute Antibody Company Information
- 12.7.2 Absolute Antibody Business Overview
- 12.7.3 Absolute Antibody Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.7.4 Absolute Antibody Bispecific and Multispecific Antibody Service Product Portfolio
- 12.7.5 Absolute Antibody Recent Developments
- 12.8 Zymeworks
- 12.8.1 Zymeworks Company Information
- 12.8.2 Zymeworks Business Overview
- 12.8.3 Zymeworks Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.8.4 Zymeworks Bispecific and Multispecific Antibody Service Product Portfolio
- 12.8.5 Zymeworks Recent Developments
- 12.9 Genedata Biologics
- 12.9.1 Genedata Biologics Company Information
- 12.9.2 Genedata Biologics Business Overview
- 12.9.3 Genedata Biologics Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.9.4 Genedata Biologics Bispecific and Multispecific Antibody Service Product Portfolio
- 12.9.5 Genedata Biologics Recent Developments
- 12.10 Creative Biolabs
- 12.10.1 Creative Biolabs Company Information
- 12.10.2 Creative Biolabs Business Overview
- 12.10.3 Creative Biolabs Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.10.4 Creative Biolabs Bispecific and Multispecific Antibody Service Product Portfolio
- 12.10.5 Creative Biolabs Recent Developments
- 12.11 ACROBiosystems
- 12.11.1 ACROBiosystems Company Information
- 12.11.2 ACROBiosystems Business Overview
- 12.11.3 ACROBiosystems Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.11.4 ACROBiosystems Bispecific and Multispecific Antibody Service Product Portfolio
- 12.11.5 ACROBiosystems Recent Developments
- 12.12 Invenra
- 12.12.1 Invenra Company Information
- 12.12.2 Invenra Business Overview
- 12.12.3 Invenra Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.12.4 Invenra Bispecific and Multispecific Antibody Service Product Portfolio
- 12.12.5 Invenra Recent Developments
- 12.13 ProteoGenix
- 12.13.1 ProteoGenix Company Information
- 12.13.2 ProteoGenix Business Overview
- 12.13.3 ProteoGenix Revenue in Bispecific and Multispecific Antibody Service Business (2021-2026)
- 12.13.4 ProteoGenix Bispecific and Multispecific Antibody Service Product Portfolio
- 12.13.5 ProteoGenix Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst